Osim inhibits ERK‐dependent Mcl‐1 phosphorylation and facilitates Mcl‐1 degradation, leading to Mcl‐1 reduction in sensitive EGFR‐mutant NSCLC cells, as we have recently demonstrated (Shi et al., 2017). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.